According to Pharma Mar's latest financial reports the company has $0.17 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.17 B | -8.01% |
2022-12-31 | $0.19 B | -14.55% |
2021-12-31 | $0.22 B | -4.93% |
2020-12-31 | $0.24 B | 927.39% |
2019-12-31 | $23.4 M | -23.87% |
2018-12-31 | $30.74 M | -19.36% |
2017-12-31 | $38.12 M | 11.9% |
2016-12-31 | $34.07 M | -31.7% |
2015-12-31 | $49.88 M | 15.51% |
2014-12-31 | $43.18 M | 8.46% |
2013-12-31 | $39.82 M | -12.56% |
2012-12-31 | $45.54 M | -28.76% |
2011-12-31 | $63.92 M | -27.82% |
2010-12-31 | $88.55 M | -2.34% |
2009-12-31 | $90.68 M | 71.58% |
2008-12-31 | $52.85 M | -0.89% |
2007-12-31 | $53.33 M | -25.2% |
2006-12-31 | $71.3 M | 64.19% |
2005-12-31 | $43.42 M | -83.97% |
2004-12-31 | $0.27 B | 68.96% |
2003-12-31 | $0.16 B | 7.18% |
2002-12-31 | $0.14 B |